Nephrocare Health IPO GMP - Live Grey Market Premium

Alloted
Nephrocare Health IPO

Nephrocare Health Services Ltd., founded in 2010, is India’s and Asia’s largest dialysis chain, providing complete dialysis care, including haemodialysis, home/mobile dialysis, and wellness programs. The company operates 519 clinics globally (51 internationally) and approximately 78% of its Indian clinics are located in Tier II and III cities. Nephrocare follows an asset-light model, partnering with major hospital chains like Max, Fortis, and Care Hospitals. The company has a track record of growth, profitability, and positive returns since recovering from losses in FY23.

Issue Price
460
Current GMP
37
GMP %
+8.04
Est. Listing Price
497
Advertisement

IPO Details

Price Range
₹438.0 - ₹460.0
Issue Size
₹871.05 Cr
Lot Size
32 shares
IPO Type
Mainboard
Open Date
10 Dec 2025
Close Date
12 Dec 2025
Allotment Date
15 Dec 2025
Listing Date
17 Dec 2025

GMP Timeline

DateIPO PriceGMPEst. Price% Change
15 Dec 2025Live
460
35
495
+7.61
14 Dec 2025
460
34
494
+7.39
13 Dec 2025
460
33
493
+7.17
12 Dec 2025
460
33
493
+7.17
11 Dec 2025
460
11
471
+2.39
10 Dec 2025
460
20
480
+4.35
9 Dec 2025
460
0
460
0.00
8 Dec 2025
460
0
460
0.00
7 Dec 2025
460
0
460
0.00
6 Dec 2025
460
0
460
0.00
5 Dec 2025
460
0
460
0.00
4 Dec 2025
460
0
460
0.00
3 Dec 2025
460
0
460
0.00
Advertisement

Important Notes About Grey Market Premium

Grey Market Premium (GMP) is an unofficial value that indicates investor sentiment before the IPO listing. It is the premium amount at which IPO shares are traded in the grey market before they are officially listed on the stock exchange.

GMP fluctuates based on market conditions and investor sentiment. A positive GMP suggests the market expects the stock to list above its issue price, while a negative GMP suggests it may list below the issue price.

The actual listing price may differ from the estimated price based on GMP due to market conditions on the listing day. GMP is not an official indicator and should not be the sole basis for investment decisions.

IPOwiz updates the GMP values regularly, but these values are sourced from unofficial channels and should be used as a reference only.

Back to GMP TrackerView Full IPO Details

Frequently Asked Questions

What is GMP (Grey Market Premium)?
GMP (Grey Market Premium) is the premium at which IPO shares are traded in the unofficial market before official listing. It indicates market sentiment and expected listing price. A positive GMP suggests strong demand, while negative GMP indicates weak market sentiment.
What is the current GMP for Nephrocare Health IPO?
The current GMP for Nephrocare Health IPO is ₹37. This represents a 8.04% premium over the issue price of ₹460.
What is the estimated listing price based on current GMP?
Based on the current GMP of ₹37 and issue price of ₹460, the estimated listing price for Nephrocare Health IPO is ₹497. However, the actual listing price may differ based on market conditions on 17 December 2025.
How is GMP calculated?
GMP is determined by market demand and supply in the unofficial grey market. It's the difference between the expected listing price and the issue price. Higher GMP indicates strong demand and investor confidence, while lower or negative GMP suggests weak demand.
Is GMP reliable for IPO investment decisions?
GMP provides market sentiment but shouldn't be the sole factor for investment decisions. It's unofficial and can change daily. Consider company fundamentals, financials, market conditions, and your risk appetite before investing. GMP is a reference indicator, not a guarantee.
Can GMP change before listing?
Yes, GMP is highly volatile and can change daily based on market conditions, subscription levels, overall market sentiment, and news about the company. The GMP you see today may be different tomorrow, and it can change until 17 December 2025.
What happens if GMP is negative?
A negative GMP indicates the stock may list below the issue price, suggesting weak market demand. However, actual listing price may differ from GMP predictions, and negative GMP doesn't guarantee a loss.
How does GMP affect IPO subscription?
High GMP often correlates with high subscription rates as investors expect good listing gains. However, this isn't always true. Some IPOs with high GMP may have lower subscription if investors are cautious. GMP reflects market sentiment, which can influence subscription behavior.
What is the estimated profit based on GMP?
For a lot size of 32 shares, the estimated profit based on current GMP of ₹37 is ₹1,184. This is calculated as: Lot Size × GMP × Number of Lots. Note: This is an estimate and actual listing price may vary.